The network collapse in multiple sclerosis: An overview of novel concepts to address disease dynamics

被引:40
|
作者
Schoonheim, Menno M. [1 ,2 ]
Broeders, Tommy A. A. [1 ]
Geurts, Jeroen J. G. [1 ]
机构
[1] Vrije Univ Amsterdam, MS Ctr Amsterdam, Dept Anat & Neurosci, Amsterdam Neurosci,Amsterdam UMC, Amsterdam, Netherlands
[2] Amsterdam UMC, Dept Anat & Neurosci, locat VUmc, POB 7057, NL-1007 MB Amsterdam, Netherlands
关键词
Multiple sclerosis; Network; Connectivity; Hub; Efficiency; Cognition; STATE FUNCTIONAL CONNECTIVITY; CLINICALLY ISOLATED SYNDROME; COGNITIVE IMPAIRMENT; BRAIN NETWORK; DISABILITY PROGRESSION; EARLY MS; DYSFUNCTION; DEFAULT; RECONFIGURATION; ROBUSTNESS;
D O I
10.1016/j.nicl.2022.103108
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
Multiple sclerosis is a neuroinflammatory and neurodegenerative disorder of the central nervous system that can be considered a network disorder. In MS, lesional pathology continuously disconnects structural pathways in the brain, forming a disconnection syndrome. Complex functional network changes then occur that are poorly un-derstood but closely follow clinical status. Studying these structural and functional network changes has been and remains crucial to further decipher complex symptoms like cognitive impairment and physical disability. Recent insights especially implicate the importance of monitoring network hubs in MS, like the thalamus and default-mode network which seem especially hit hard. Such network insights in MS have led to the hypothesis that as the network continues to become disconnected and dysfunctional, exceeding a certain threshold of network efficiency loss leads to a "network collapse". After this collapse, crucial network hubs become rigid and overloaded, and at the same time a faster neurodegeneration and accelerated clinical (and cognitive) progression can be seen. As network neuroscience has evolved, the MS field can now move towards a clearer classification of the network collapse itself and specific milestone events leading up to it. Such an updated network-focused conceptual framework of MS could directly impact clinical decision making as well as the design of network -tailored rehabilitation strategies. This review therefore provides an overview of recent network concepts that have enhanced our understanding of clinical progression in MS, especially focusing on cognition, as well as new concepts that will likely move the field forward in the near future.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Validating a novel web-based method to capture disease progression outcomes in multiple sclerosis
    Leddy, Sara
    Hadavi, Shahrzad
    McCarren, Andrew
    Giovannoni, Gavin
    Dobson, Ruth
    JOURNAL OF NEUROLOGY, 2013, 260 (10) : 2505 - 2510
  • [42] Validating a novel web-based method to capture disease progression outcomes in multiple sclerosis
    Sara Leddy
    Shahrzad Hadavi
    Andrew McCarren
    Gavin Giovannoni
    Ruth Dobson
    Journal of Neurology, 2013, 260 : 2505 - 2510
  • [43] Vaccination in multiple sclerosis patients treated with highly effective disease-modifying drugs: an overview with consideration of cladribine tablets
    Gold, Ralf
    Faetkenheuer, Gerd
    Hartung, Hans-Peter
    Kleinschnitz, Christoph
    Marks, Reinhard
    Maschke, Matthias
    Bayas, Antonios
    Loebermann, Micha
    Zettl, Uwe K.
    Wiendl, Heinz
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [44] Optical coherence tomography angiography indicates associations of the retinal vascular network and disease activity in multiple sclerosis
    Feucht, Nikolaus
    Maier, Mathias
    Lepennetier, Gildas
    Pettenkofer, Moritz
    Wetzlmair, Carmen
    Daltrozzo, Tanja
    Scherm, Pauline
    Zimmer, Claus
    Hoshi, Muna-Miriam
    Hemmer, Bernhard
    Korn, Thomas
    Knier, Benjamin
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (02) : 224 - 234
  • [45] Interleukin 35 and Hepatocyte Growth Factor; as a novel combined immune gene therapy for Multiple Sclerosis disease
    Moghadam, Samira
    Erfanmanesh, Maryam
    Esmaeilzadeh, Abdolreza
    MEDICAL HYPOTHESES, 2017, 109 : 102 - 105
  • [46] The Diversity of Astrocyte Activation during Multiple Sclerosis: Potential Cellular Targets for Novel Disease Modifying Therapeutics
    Barmpagiannos, Konstantinos
    Theotokis, Paschalis
    Petratos, Steven
    Pagnin, Maurice
    Einstein, Ofira
    Kesidou, Evangelia
    Boziki, Marina
    Artemiadis, Artemios
    Bakirtzis, Christos
    Grigoriadis, Nikolaos
    HEALTHCARE, 2023, 11 (11)
  • [47] Integrating single-nucleus sequence profiling to reveal the transcriptional dynamics of Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis
    Li-Yuan Fan
    Jing Yang
    Ruo-Yu Liu
    Ying Kong
    Guang-Yu Guo
    Yu-Ming Xu
    Journal of Translational Medicine, 21
  • [48] Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis
    Samjoo, Imtiaz A.
    Worthington, Evelyn
    Drudge, Christopher
    Zhao, Melody
    Cameron, Chris
    Haering, Dieter A.
    Stoneman, Dee
    Klotz, Luisa
    Adlard, Nicholas
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (18) : 1255 - 1274
  • [49] Integrating single-nucleus sequence profiling to reveal the transcriptional dynamics of Alzheimer's disease, Parkinson's disease, and multiple sclerosis
    Fan, Li-Yuan
    Yang, Jing
    Liu, Ruo-Yu
    Kong, Ying
    Guo, Guang-Yu
    Xu, Yu-Ming
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [50] A Metagenome-Wide Association Study of Gut Microbiome in Patients With Multiple Sclerosis Revealed Novel Disease Pathology
    Kishikawa, Toshihiro
    Ogawa, Kotaro
    Motooka, Daisuke
    Hosokawa, Akiko
    Kinoshita, Makoto
    Suzuki, Ken
    Yamamoto, Kenichi
    Masuda, Tatsuo
    Matsumoto, Yuki
    Nii, Takuro
    Maeda, Yuichi
    Nakamura, Shota
    Inohara, Hidenori
    Mochizuki, Hideki
    Okuno, Tatsusada
    Okada, Yukinori
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2020, 10